Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma

Laryngoscope

Volumn 117, Issue 8, 2007, Pages 1376-1380

  Nayak, Chetan S ^a   Carvalho, André Lopes ^a   Jeronimo, Carmen ^a   Henrique, Rui ^a   Kim, Michael M ^a   Hoque, Mohammad O ^a   Chang, Steve ^a   Jiang, Wei Wen ^a   Koch, Wayne ^a   Westra, William ^a   Sidransky, David ^a   Califano, Joseph ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

DAP kinase; Head and neck squamous cell carcinoma; Hypermethylation; Quantitative PCR; TIMP 3; Tumor suppressor gene

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ALCOHOL CONSUMPTION; ARTICLE; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC ANALYSIS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

AGED; APOPTOSIS REGULATORY PROTEINS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; METHYLATION; METHYLTRANSFERASES; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR MARKERS, BIOLOGICAL;

EID: 34548449339     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31806865a8     Document Type: Article

References (14)

1. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 2005;114:806-816.
2. Rosas SL, Koch W, da Costa Carvalho MG, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001;61:939-942.
3. Goldenberg DHS, Masayesva BG, Ha P, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004;130:39-44.
4. Bond MMG, Bennett MR, Newby AC, Baker AH. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. J Biol Chem 2002;277:13787-13795.
5. Brueckl WM, Wein A, Ruckert S, et al. Alterations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) are found frequently in human colorectal tumors displaying either microsatellite stability (MSS) or instability (MSI). Cancer Lett 2005;223:137-142.
6. Yokoyama TNH, Otani Y, Kubota T, Fujimoto N, Seiki M, Kitajima M, Okada Y. Difference between scirrhous and non-scirrhous human gastric carcinoma from the aspect of proMMP-2 activation regulated by TIMP-3. Clin Exp Metastasis 2004;21:223-233.
7. Worsham MJ, Chen KM, Meduri V, Nygren AOH, Errami A, Schouten JP, Benninger MS. Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132:668-677.
8. Reddy AN, Jiang WW, Kim M, et al. Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res 2003;63:7694-7698.
9. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
10. Levy-Strumpf N, Kimchi A. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene 1998;17:3331-3340.
11. Raveh T, Kimchi A. DAP kinase - a proapoptotic gene that functions as a tumor supressor. Exp Cell Res 2001;264:185-192.
12. Inbal B, Cohen O, Polak-Charcon S, Kopolovic J, Vadai E, Eisenbach L, Kimchi A. DAP-kinase links the control apoptosis to metastasis. Nature 1997;390:180-184.
13. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 2002;21:4231-4236.
14. Ishida E, Nakamura M, Ikuta M, Shimada K, Matsuyoshi S, Kirita T, Konishi N. Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma. Oral Oncol 2005;41:614-22.